Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 23, 2024 (Week 47)
Reporting Area Carbapenemase-Producing Organisms (CPO), Total §,¶
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 69 NC 4,254 6,193
New England 1 NC 71 100
Connecticut - NC - -
Maine - NC 23 42
Massachusetts - NC - -
New Hampshire - NC 15 24
Rhode Island 1 NC 32 31
Vermont - NC 1 3
Middle Atlantic - NC 149 526
New Jersey - NC - -
New York (excluding New York City) - NC - -
New York City - NC - 229
Pennsylvania - NC 149 297
East North Central 38 NC 1,964 2,543
Illinois - NC 50 662
Indiana - NC 234 361
Michigan 1 NC 194 308
Ohio 37 NC 1,353 1,171
Wisconsin - NC 133 41
West North Central - NC 144 247
Iowa - NC 56 77
Kansas - NC 80 80
Minnesota - NC - 73
Missouri - NC - -
Nebraska - NC - -
North Dakota - NC - 11
South Dakota - NC 8 6
South Atlantic 8 NC 564 780
Delaware - NC 15 12
District of Columbia - NC - -
Florida N NC N N
Georgia - NC - 280
Maryland - NC - -
North Carolina - NC - 166
South Carolina - NC - -
Virginia 8 NC 442 238
West Virginia - NC 107 84
East South Central 6 NC 93 206
Alabama N NC N N
Kentucky - NC - -
Mississippi 6 NC 93 206
Tennessee - NC - -
West South Central - NC - 22
Arkansas - NC - -
Louisiana - NC - 22
Oklahoma - NC - -
Texas U NC U U
Mountain 16 NC 1,249 925
Arizona 14 NC 1,144 764
Colorado - NC - -
Idaho - NC - -
Montana - NC 8 1
Nevada - NC 2 94
New Mexico 2 NC 52 -
Utah - NC 43 65
Wyoming - NC - 1
Pacific - NC 20 844
Alaska - NC - -
California - NC - 722
Hawaii - NC - 20
Oregon - NC 20 25
Washington - NC - 77
U.S. Territories - NC - 166
American Samoa - NC - -
Commonwealth of Northern Mariana Islands - NC - -
Guam - NC - -
Puerto Rico - NC - 166
U.S. Virgin Islands - NC - -
Non-U.S. Residents - NC 2 -
Total 69 NC 4,256 6,359
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.
  • ¶ CPO (total) includes CP-CRE cases reported in MMWR year 2023, and CPO clinical and CPO screening cases reported in both MMWR years 2023 and 2024.